1. Diabetes care and research in Europe: the Saint-Vincent Declaration. Diabetic medicine 7:360-364; 1990
2. Roglic G et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, 2005, 28:2130-2135.
3. Beaglehole R, Epping-Jordan J. Preventing chronic diseases, a vital investment. Geneva, World Health Organization, 2005.
4. Wild S et al Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27:10471053.
5. Internatonal Diabetes Federation. Diabetes a/as, 2nd ed. Brussels, Belgium, 2003.
6. Engelgau MM et al The evolving diabetes burden in the United States. Annals of Internal Medicine, 2004, 140:945-950.
7. Centers for Disease Control and Prevention. Diabetes surveillance system. National diabetes factsheet. Atlanta, Georgia, 2003.
8. Gu D et al Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia, 2003, 46:1190-1198.
9. Worid Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, 1999 (WHO/NCD/NCS/99.2), Geneva.
10. Pan XR et al Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study Diabetes Care, 1997, 20:537-544.
11. Tuomilehto J et al Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Mediane, 2001, 344:13431350.
12. Knowler WC et al Reduction in the incidence of type 2 diabetes with lüestyle intervention or metformin. New England Journal of Medicine, 2002, 346:393-403.
13. Chiasson JL et al Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Lancet, 2002, 359:2072-2077.
14. Torgerson JS et al XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of oriistat as an adjunct to Iüestye changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004, 27:155-161.
15. Xiang AH et al Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes, 2006, 55:517-522.
16. Ken R et al The Wisconsin epidemiologic study of diabetic retinopathy II Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 1984, 102:520-526.
17. Ken R et al The Wisconsin epidemiologic study of diabetic retinopathy III Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology, 1984, 102:527-532.
18. Resnikoff S et al Global data on visual impairment in the year 2002. Bulletin of the World Heath Organization, 2004, 82:844-851.
19. Ken R, Kein BEK, Moss SE, Linton KL. The Beaver Dam Eye
Study Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1991;99:58-62.
20. Klein R, Klein BEK. Vision disorders in diabetes. Diabetes in Amerca. 2nd ed.Washigton, DC: US Government Prnting Office; 1995
21. http://www.cdc.gov/diabetes/pubs/estmates.htm. Accessed 15 June 2006.
22. Klein R. Estimates prepared for the Diabetes 2000 program, based upon the Wisconsin Epidemiological Study of Diabetic Retinopathy. San Francisco, California, American Academy of Ophthalmology, 1989.
23. Ferrs FL. Results of 20 years of research on the treatment of diabetic retinopathy Preventive Medicine, 1994, 23:740-742.
24. DRS Study Group. Photocoagulation treatment of proliierative diabetic retinopathy Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology, 1981, 88:583-600.
25. Vine AK. The efficacy of additional argon laser photocoagulation for persistent, severe proliierative diabetic retinopathy Ophthalmology, 1985, 932:1532-1537.
26. ETDRS Study Research Group. Photocoagulation for diabetic macular edema. ETDRS report number 1. Archives of Ophthalmology, 1985, 103:1796-1806.
27. ETDRS Study Research Group. Early photocoagulation for diabetic retinopathy, ETDRS report number 9. Ophthalmology, 1991; 98 (Suppl 5):766-785.
28. Diabetic Retinopathy Vitrectomy Study Two-year course of visual acuity in severe proliierative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report No. 1. Ophthalmology, 1985, 92:492-502.
29. Diabetic Retinopathy Vitrectomy Study Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy Two-year results of a randomized tral. DRVS report 2. Archives of Ophthalmology, 1985, 103:1644-1652.
30. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 1993, 329:977-986.
31. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Tral Ophthalmology, 1995, 102:647-661.
32. Diabetes Control and Complications Tral The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Archives of Ophthalmology, 1995, 113:36-51.
33. Diabetes Control and Complications Tral/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. New England Journal of Medicine, 2000, 342:381-389.
34. http7/www cdc.gov/diabetes/pubs/esti mates. htm#complications. Accessed 14 June 2005.
35 . Writing Team for the Diabetes Control and Complications
Trial/Epidemiology of Diabetes Interventions and Complications Research Group . The Journal of American Medical Association, 2002, 287:2563-2569.
36 . Stratton IM et al. UKPDS 50: risk factors for incidence and progressions of retinopathy in type II diabetes over 6 years from diagnosis. Diabetoiogia, 2001, 44:156-163.
37 . Mathews DR et al Risks of progression of retinopathy and vsion loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 60. Archives of Ophthalmology, 2004, 122:16311640.
38. Brechner RJ et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA, 1993, 270:1714-1718.
39. McGlynn EA et al. The quality of health care delivered to adults in the United States. New England Journal of Medicine, 2003, 348:2635-2645.
40. Kerr EA et al. Profiling the quality of care in twelve communities: results from the CQI study. Health Affairs (Milwood), 2004, 23:247256.
41. Weiner JP et al. Variation in office-based quality: a dams-based profile of care provided to Medicare patients with diabetes. JAMA, 1995, 273:1503-1508.
42. Will JC et al. Patient adherence to guidelines for diabetes eye care from the diabetic eye disease follow-up study. American Journal of Public HeaMh, 1994, 84:1669-1671.
43. Vitale S. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: what can we learn at 14 years? (editorial). Ophthalmology, 1998, 105:1799-1800.
44. Newcomb PA, Kein R. Factors associated with compliance following diabetic eye screening. Journal of Diabetes and its Complications, 1990, 4:8-14.
45. Moss SE, Ken R, Ken BE. Factors associated with having eye examinations in persons with diabetes. Archives of Family Medicine, 1995, 4:529-534.
46. Javiit JC et al. Detecting and treating retinopathy in patients with type 1 diabetes: savings associated with improved implementation of current guidelines. Ophthalmology, 1991, 98:1565-1574.
47. Dasbach EJ et al. Cost-effectiveness of strategies for detecting diabetic retinopathy. Medical Care, 1991, 29:20-39.
48. Harris R et al. Screening adults for type 2 diabetes: a review of the evdence for the US Preventive Seraces Task Force. Annals of Internal Medicine, 2003, 138:215-229.
49. O'Connor PJ, Spann SJ, Wool SH. Care of adults with type 2 diabetes mellitus: a review of the evdence. Journal of Family Practice, 1998, 47 (Suppl 5):S13-S22.
50. American Academy of Ophthalmology. Preferred practice pattern: diabetes mellitus. San Francisco, Calüornia, 2005.
51. American Optometric Association. Optometnc clinical practice guideline: care of the patient with diabetes mellitus. St. Louis, Missouri, 2002.
52. International Council of Ophthalmology. Guideline. http://www.icoph.org/guide/guideist.html.
53. Led TR, Sheingold S. HEDIS performance trends in Medicare managed care. Health Care Finance Review, 2001, 23:149-160.
54. Kuo S et al. Trends in care practices and outcomes among medicare beneficiares with diabetes. American Journal of Preventive Medicine, 2005, 29:396-403.
55. Lee PP et al. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology, 2003, 110:1942-1949.
56. Weiner JP. Forecasting the effects of health reform on US physician workforce requirement: evidence from HMO staffing patterns. JAMA, 1994, 272:222-230.
57. Cooper RA et al. Economic and demographic trends signal an impending physician shortage. Health Affairs (Millwood), 2002, 21:140-154.
58. Lee PP, VanBoemel G, Smith RE. Why patients with diabetes lose vsion: provder perspectives (abstract). Investigative Ophthalmology and Visual Science, 1998; 39 (Suppl):S116.
59. Livrngston PM et al. Use of focus groups to identify health promotion strategies for the early detection of diabetic retinopathy. Australia New Zealand Journal of Public Health, 1998, 22:220-222.
60. Trento M et al. Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabetic Medicine, 2002, 19:810-813.
61. Sussman EJ, Tsiaras WG, Soper KA. Diagnosis of diabetic eye disease. JAMA, 1982, 247:3231-3234.
62. Kleinstein RN et al. Detection of diabetic retinopathy by optometrists. Journal of the American Optometric Association, 1987, 58:879-882.
63. Schmid KL et al. The detection of diabetic retinopathy by Australian optometrists. Clinical and Experimental Optometry, 2002, 85:221228.
64. Prasad S et al. Effectiveness of optometrist screening for diabetic retinopathy using slit-amp biomicroscopy. Eye, 2001, 15:595-601.
65. Lee VS et al. The diagnosis of diabetic retinopathy: ophthalmoscopy versus fundus photography. Ophthalmology, 1993, 100:1504-1512.
66. Awh CC, Cupples HP, Javitt JC. Improved detection and referral of patents with diabetic retinopathy by prmary care physicians: effectiveness of education. Archives of Internal Medicine, 1991, 151:1405-1408.
67. Bibby K et al. Benefits of training junior physicians to detect diabetic retinopathy—the Glasgow experience. Journal of the Royal Society of Medicine, 1992, 85:326-328.
68. Confos N, Frith J, Mitchell P. Training GPs to screen for diabetic retinopathy. Australian Family Physician, 2003, 32:381-384.
69. Nathan DM et al. Role of diabetologist in evaluating diabetic retinopathy. Diabetes Care, 1991, 14:26-33.
70. Gil JM et al. Accuracy of screening for diabetic retinopathy by family physicians. Annals of Family Medicine, 2004, 2:218-220.
71. Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic revews. International Journal of Technology Assessment in Health Care, 2005, 21:380-385.
72. Lee P. Telemedicine: opportunities and challenges for the remote care of diabetic retinopathy (editoral). Archives of Ophthamology, 1999, 117:1639-1640.
73. Williams GA et al. Single field fundus photography for diabetic retinopathy screening: a report by the Amercan Academy of Ophthalmology. Ophthalmology, 2004, 111:1055-1062.
74. Amercan College of Radiology. ACR standard for teleradiology (Res 21-1994). Chicago, IIIinois, 1998.
75. Whited JD. Accuracy and reliability of teleophthalmology for diagnosing diabetic retinopathy and macular edema: a review of the literature. Diabetes Technology and Therapeutics, 2006, 8:102111.
76. Kinyoun J et al. Detection of diabetic macular edema: ophthalmoscopy versus photography—ETDRS report number 5. Ophthalmology, 1989, 96:746-750.
77. Pugh JA et al. Screening for diabetic retinopathy. Diabetes Care, 1993, 16:889-895.
78. Basu A et al. Is digital compression acceptable within diabetic retinopathy screening. Diabetic Medicine, 2003, 20:766-771.
79. Baker CF et al. JPEG compression of stereoscopic digital images for the diagnosis of diabetic retinopathy via teleophthalmology. Canadian Journal of Ophthalmology, 2004, 39:746-754.
80. Lim JI et al. A comparison of digital nonmydratic fundus imaging with standard 35-millimeter sides for diabetic retinopathy.
Ophthalmology, 2000, 107:866-870.
81. Cavallerano JD et al. Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mid diabetic retinopathy. American Journal of Ophthalmology, 2005, 140:667-673.
82. Fransen SR et al. Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology, 2002, 109:595-601.
83. Pandit RJ, Taylor R. Quality assurance in screening for sight-threatening diabetic retinopathy. Diabetic Mediane, 2002, 19:285291.
84. Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. Diabetic Medicine, 2006, 13:946-952.
85. West SK, Taylor HR. Reliability of photographs for grading trachoma in field studies. British Journal of Ophthalmology, 1990, 74:12-13.
86. Solomon AW, Bowman RJ, Yorston D. Operational evaluation of the use of photographs for grading active trachoma. American Journal of Tropical Medicine and Hygiene, 2006, 74:505-508.
87. Chylack LT et al. The lens opacities classification system III. Archives of Ophthalmology, 1993, 111:831-836.
88. Spaeth GL et al. The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma. Transactions of the American Ophthalmology Society, 2002, 100:181-185.
89. Dickson PR et al. Diabetic retinopathy: examination practices and referral patterns of general practitioners. Medical Journal of Australia, 1996, 164:341-344.
90. McCarty CA, Tay or KT, Keeffe J. Management of diabetic retinopathy by general practitioners in Victoria. Clinical and Experimental Ophthalmology, 2001, 29:12-16.
91. Kraft SK et al. Primary care physicians' practice patterns and diabetic retinopathy: current levels of care. Archives of Family Medicine, 1997; 6:29-37.
92. Smith AF. Current and possible screening practices for diabetic retinopathy by general practitioners: new evidence from a plot study of Oxfordshire general practitioners. Ophthalmic Epdiemlology, 1995, 2:129-135.
93. Namperumalsamy, P. et.al. Diabetes Care 26: 1831-1835, 2003
94. Verdauger TJ. Screening for diabetic retinopathy in Latin America. Revista Sociedad Brazil Retina Vitreous, 2001, 4:14-15.
96. Khadem JJ, Buzney SM, Aich KS. Practice patterns in diabetic retinopathy Archives of Ophthalmology, 1999, 117:815-820.
97. Hall J, Abrecht K, Lee P. Conformance with the preferred practice pattern for diabetic eye care. Retina, 1998, 18:160-163.
98. McCarty CA et al. Changes in management of diabetic retinopathy by Australian ophthalmologists as a result of the NHRMC clinical guidelines. Clinical and Experimental Ophthalmology, 2001, 29:230-234.
99. McCarty CA et al. Diabetic retinopathy: effects of national guidelines on the referral, examination, and treatment practices of ophthalmologists and optometrists. Clinical and Experimental Ophthalmology, 2001, 29:52-58.
100. Wilkinson CP et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 2003, 110:1677-1682.
101. Namperumalsamy P et al. A plot study on awareness of diabetic retinopathy among non-medical persons in South India: the change for eye care programs in the region. Indian Journal of Ophthalmology, 2004, 53:247-251.
102. Li H, Tang R, Crump W: Teleophthalmology at the University of Texas Medical Branch (abstract). Amercan Academy of Ophthalmology Annual Meeting Final Programme, 158, 1996.
Was this article helpful?
All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.